Company Overview of Omega Pharma Invest NV
Omega Pharma Invest NV, together with its subsidiaries, develops and markets prescription-free health and personal care products. It operates in two segments Omega Pharma Belgium, and Omega Pharma Other. The company offers personal care products for face and body, sun care products, and baby-specific products under the Bodysol/Galenco, ACO, and Lactacyd brands, as well as Claire Fisher, Bergasol, and Biodermal brands; and medical skin care products for various skin conditions and allergies, as well as to cleanse and disinfect the skin under the Dermalex (Repair), Septivon, and Wartner brands. It also provides cough, cold, and allergy products under the Bittner/Aflubin, Prevalin/Beconase, Phy...
Industrial Zoning De Prijkels
Founded in 1987
Key Executives for Omega Pharma Invest NV
Compensation as of Fiscal Year 2016.
Omega Pharma Invest NV Key Developments
Omega Pharma and Novamedica to Market Line of Gastrointestinal Products Under BenegastTM Brand in Russia
Jan 22 15
NovaMedica and Omega Pharma signed a partnership agreement granting NovaMedica exclusive rights to promote, distribute and sell a line of OTC gastrointestinal products under the BenegastTM umbrella brand in Russia. Partnering with Omega Pharma is in line with NovaMedica's strategy and focus on delivering innovative treatments for gastrointestinal (GI) patients. NovaMedica plans to start marketing Benegast products in January 2015. NovaMedica intends to actively promote Benegast products to pharmacies throughout Russia, and will launch a national advertising campaign.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries